Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Novotech

< Previous 1 2 3 Next >
New Novotech Report Finds 1,000 HIV Clinical Trials Globally
From Novotech
Via GlobeNewswire
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global Biotech Clinical Trials in 2024
From Novotech
Via GlobeNewswire
Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials
From Novotech
Via GlobeNewswire
Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide
From Novotech
Via GlobeNewswire
Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis
From Novotech
Via GlobeNewswire
Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data
From Novotech
Via GlobeNewswire
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Korea Summit
From Novotech
Via GlobeNewswire
Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award
From Novotech
Via GlobeNewswire
Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services
From Novotech
Via GlobeNewswire
Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
From Novotech
Via GlobeNewswire
Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News
From Novotech
Via GlobeNewswire
Novotech Releases Comprehensive Global Landscape Report on Gallbladder Cancer Clinical Trials
From Novotech
Via GlobeNewswire
Novotech Publishes Nasopharyngeal Carcinoma Global Clinical Trial Landscape Report
From Novotech
Via GlobeNewswire
Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023
From Novotech
Via GlobeNewswire
Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA 2023
From Novotech
Via GlobeNewswire
Novotech Selected for Biotech CRO Leadership Award 2023
From Novotech
Via GlobeNewswire
Novotech Sponsors BIO 2023 APAC Summit and the Endpoints Panel on Forging Biotech Ties with China
From Novotech
Via GlobeNewswire
Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development Acceleration with Endpoints for ASCO 2023
From Novotech
Via GlobeNewswire
Industry Survey Identifies Successful Biotech Clinical Trial Strategies
From Novotech
Via GlobeNewswire
Novotech Joins Expert Panel at AACR for eChinaHealth Session on Collaborating with China’s Cancer Research Sector
From Novotech
Via GlobeNewswire
GlobalData Publishes FDA Regulatory Guidance and Strategy Report for Biotech Approval Pathways
From Novotech
Via GlobeNewswire
Novotech Publishes Multi-specific Monoclonal Antibodies Global Clinical Trial Landscape Report
From Novotech
Via GlobeNewswire
Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations
From Novotech
Via GlobeNewswire
Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends
From Novotech
Via GlobeNewswire
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
From Novotech
Via GlobeNewswire
Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug Development and FDA Regulatory Expertise
From Novotech
Via GlobeNewswire
Novotech Acquires European CRO – Strengthens Global Operations
From Novotech
Via GlobeNewswire
Novotech is Gold Sponsor at Biotech Showcase 2023
From Novotech
Via GlobeNewswire
Data Shows 50% of New Trials Have Sites in Asia Pacific
From Novotech
Via GlobeNewswire
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
From Novotech
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.